Design Therapeutics, Inc. (DSGN)

CIK 1807120 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Design Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Aug 14, 2026SCHEDULE 13G/A0000919574-26-005487
Aug 14, 2026SCHEDULE 13G0000919574-26-005202
Aug 3, 20268-K0001193125-26-329570
Aug 3, 202610-Q0001193125-26-329579
Jun 11, 202640001193125-26-267732
Jun 11, 202640001478916-26-000009
Jun 11, 202640001579826-26-000002
Jun 11, 20268-K0001193125-26-267485
Jun 11, 202640001754129-26-000006
Jun 11, 202640001559570-26-000008
Jun 11, 202640001751873-26-000002
Jun 9, 2026SCHEDULE 13G0000919574-26-003921
May 18, 20268-K0001193125-26-227875
May 15, 2026SCHEDULE 13G/A0000919574-26-003492
Apr 28, 202610-Q0001193125-26-187063
Apr 28, 20268-K0001193125-26-187012
Apr 23, 2026DEF 14A0001193125-26-173678
Apr 23, 2026DEFA14A0001193125-26-173689
Apr 23, 2026ARS0001193125-26-173640
Apr 1, 202630001559570-26-000004
Apr 1, 202640001559570-26-000006
Apr 1, 20268-K0001193125-26-137861
Mar 11, 2026SCHEDULE 13D/A0001072613-26-000257
Mar 9, 202610-K0001193125-26-098491
Mar 9, 20268-K0001193125-26-098474